Saturday 17 October 2026
Export CCM’s income statement to Excel — free account
Concord Medical Services Holdings Limited
CCM Healthcare Medical Care Facilities
Concord Medical Services Holdings Limited’s revenue for fiscal 2025 (year ended December 2025) was $65.9 million, up 25.2% from fiscal 2024.
3.63
0.08
−2.16%
Follow CCM
| Older periods | Dec '22 | Jun '23 | Jun '24 | Jun '25 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
0.00 | 0.00 | — | — |
P/S ratio |
3.52 | 2.49 | — | — | |
P/FCF ratio |
7.54 | 5.75 | — | — | |
P/Operating CF |
6.44 | 4.92 | — | — | |
P/B ratio |
0.00 | 1.35 | — | — | |
Price to Tangible BV |
0.00 | 2.40 | — | — | |
EV/Sales |
6.57 | 4.74 | — | — | |
EV/EBITDA |
0.00 | 0.00 | — | — | |
EV/Operating CF |
6.96 | 5.41 | — | — | |
EV/FCF |
14.05 | 10.92 | — | — | |
Quick Ratio |
0.26 | 0.27 | 0.19 | 0.10 | |
Current Ratio |
0.68 | 0.64 | 0.47 | 0.42 | |
Net Debt/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
Debt/Assets |
53.21% | 46.09% | 45.38% | 45.01% | |
Debt/Equity |
(1.73) | 1.34 | 1.56 | 1.76 | |
Asset Turnover |
0.17 | 0.18 | 0.00 | 0.00 | |
Operating CF/Net income |
0.00 | 0.00 | — | — | |
Interest Coverage |
0.00 | 0.00 | — | — | |
Research and Development Expense of Revenue |
0.00% | 0.00% | — | — | |
Selling, General and Administrative Expense of Revenue |
65.82% | 62.07% | — | — | |
Intangible Assets out of Total Assets |
0.15 | 0.15 | 0.13 | 0.13 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | — | — | |
Graham Net Nets |
(0.93) | (1.11) | — | — | |
Graham Number |
13.85 | 0.00 | — | — | |
Earnings Yield |
(4.89%) | (6.38%) | — | — | |
Free Cash Flow Yield |
13.27% | 17.39% | — | — | |
Revenue per Share |
1.68 | 1.46 | — | — | |
Operating CF per Share |
0.00 | 0.00 | — | — | |
Capex per Share |
0.00 | 0.00 | — | — | |
Free Cash Flow per Share |
0.00 | 0.00 | — | — | |
Cash per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Shareholders Equity per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/EBIT |
0.00 | 0.00 | — | — | |
Capex to Sales |
0.00 | 0.00 | — | — | |
Price to Operating Income |
0.00 | 0.00 | — | — | |
| Other line items | |||||
Working Capital |
(51.99) | (66.89) | (157.26) | (199.48) | |
Net Current Asset Value |
(471.29) | (431.82) | (505.34) | (556.44) | |
Average Receivables |
25.21 | 13.71 | 15.63 | 10.94 | |
Average Payables |
11.98 | 9.69 | 16.80 | 15.88 | |
Average Inventory |
12.44 | 6.10 | 5.73 | 6.17 | |
Average Assets |
847.25 | 886.24 | 948.11 | 941.35 | |
Average Common Equity |
(184.75) | 70.06 | 24.67 | 5.56 |
Columns are period end dates